Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Reichert, Zachery R."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-2 z 2
    Tytuł:
    Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer.
    Autorzy:
    Dadhania V; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
    Gonzalez D; Department of Pathology and Laboratory Medicine, Jackson Memorial Hospital, Miami, FL, USA.
    Yousif M; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.; Department of Pathology, Vanderbilt University Medical Center, Nashville, TN, USA.
    Cheng J; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
    Morgan TM; Department of Urology, University of Michigan Medical School, Ann Arbor, MI, USA.
    Spratt DE; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
    Reichert ZR; Department of Medical Oncology, University of Michigan Medical School, Ann Arbor, MI, USA.
    Mannan R; Michigan Center for Translational Pathology, Ann Arbor, MI, USA.
    Wang X; Michigan Center for Translational Pathology, Ann Arbor, MI, USA.
    Chinnaiyan A; Michigan Center for Translational Pathology, Ann Arbor, MI, USA.
    Cao X; Michigan Center for Translational Pathology, Ann Arbor, MI, USA.
    Dhanasekaran SM; Michigan Center for Translational Pathology, Ann Arbor, MI, USA.
    Chinnaiyan AM; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.; Department of Urology, University of Michigan Medical School, Ann Arbor, MI, USA.; Michigan Center for Translational Pathology, Ann Arbor, MI, USA.; Rogel Cancer Center, Michigan Medicine, Ann Arbor, MI, USA.; Howard Hughes Medical Institute, Ann Arbor, MI, USA.
    Pantanowitz L; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.; Rogel Cancer Center, Michigan Medicine, Ann Arbor, MI, USA.
    Mehra R; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. .; Michigan Center for Translational Pathology, Ann Arbor, MI, USA. .; Rogel Cancer Center, Michigan Medicine, Ann Arbor, MI, USA. .
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2022 May 05; Vol. 22 (1), pp. 494. Date of Electronic Publication: 2022 May 05.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Adenocarcinoma*/diagnosis
    Adenocarcinoma*/genetics
    Adenocarcinoma*/pathology
    Prostatic Neoplasms*/pathology
    Artificial Intelligence ; Gene Fusion ; Humans ; In Situ Hybridization, Fluorescence ; Male ; Oncogene Proteins, Fusion/genetics ; Transcriptional Regulator ERG/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).
    Autorzy:
    Reichert ZR; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
    Kasputis T; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.
    Nallandhighal S; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.
    Abusamra SM; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.
    Kasputis A; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.
    Haruray S; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.
    Wang Y; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.
    Williams S; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.
    Singhal U; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.; Department of Urology, Mayo Clinic, Rochester, MN 55901, USA.
    Alva A; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, Ann Arbor, MI 48109, USA.
    Cackowski FC; Division of Medical Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.
    Caram MEV; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
    Palmbos PL; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
    Yentz SE; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Lieutenant Colonel Charles S. Kettles VA Medical Center, Ann Arbor, MI 48105, USA.
    Smith DC; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
    Alumkal JJ; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.
    Morgan TM; Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Department of Urology, University of Michigan, Ann Arbor, MI 48109, USA.
    Pokaż więcej
    Źródło:
    International journal of molecular sciences [Int J Mol Sci] 2021 Dec 21; Vol. 23 (1). Date of Electronic Publication: 2021 Dec 21.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Drug Resistance, Neoplasm*
    Biomarkers, Tumor/*genetics
    Gene Expression Profiling/*methods
    Neoplastic Cells, Circulating/*chemistry
    Prostatic Neoplasms/*genetics
    Androgen Antagonists/pharmacology ; Androgen Antagonists/therapeutic use ; Antigens, Neoplasm/genetics ; Desmoglein 2/genetics ; Humans ; Kallikreins/genetics ; Male ; Midkine/genetics ; Multiplex Polymerase Chain Reaction ; Precision Medicine ; Prognosis ; Prospective Studies ; Prostate-Specific Antigen/genetics ; Prostatic Neoplasms/drug therapy ; Receptors, Androgen/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-2 z 2

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies